Published in Cell Res on September 01, 2006
Tissue inhibitor of metalloproteinases-4. The road less traveled. Mol Cancer (2008) 1.17
GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression. Cancer Med (2012) 0.91
The present and future of prostate cancer urine biomarkers. Int J Mol Sci (2013) 0.85
Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells. Mol Cell Proteomics (2014) 0.84
Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion. Biochem J (2007) 0.81
TIMPs: versatile extracellular regulators in cancer. Nat Rev Cancer (2016) 0.79
Effects of detergents on catalytic activity of human endometase/matrilysin 2, a putative cancer biomarker. Anal Biochem (2009) 0.77
The Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer Cells. J Cancer (2013) 0.76
Evidence for a Proapoptotic Role of Matrix Metalloproteinase-26 in Human Prostate Cancer Cells and Tissues. J Cancer (2016) 0.75
Peaking of MMP-26 and TIMP-4 marks invasive transition in prostate cancer. Cell Res (2006) 0.75
Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA. J Cancer (2011) 0.75
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res (2007) 2.77
Replication-independent histone deposition by the HIR complex and Asf1. Curr Biol (2005) 2.40
Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol (2006) 2.09
Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res (2013) 2.00
Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol (2010) 1.73
Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology (2003) 1.62
Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One (2009) 1.57
The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. Exp Cell Res (2004) 1.33
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem (2003) 1.31
High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol (2005) 1.20
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2009) 1.18
MicroRNAs 373 and 520c are downregulated in prostate cancer, suppress CD44 translation and enhance invasion of prostate cancer cells in vitro. Int J Clin Exp Pathol (2008) 1.16
Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria. BMC Urol (2009) 1.14
A working group classification of focal prostate atrophy lesions. Am J Surg Pathol (2006) 1.13
Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res (2009) 1.13
Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18. Lab Invest (2004) 1.13
Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion. Cancer Res (2004) 1.13
Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases. Curr Top Med Chem (2006) 1.12
Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer. BMC Cancer (2005) 1.07
Sarcomatoid carcinoma of transitional cell origin confined to renal pelvis. Urology (2006) 1.07
Reconstruction of protein networks from an atlas of maize seed proteotypes. Proc Natl Acad Sci U S A (2013) 1.07
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer (2008) 1.05
Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26. J Biol Chem (2002) 1.03
Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association. PLoS One (2008) 1.01
Update on options for treatment of metastatic castration-resistant prostate cancer. Onco Targets Ther (2010) 1.00
Candida albicans RFX2 encodes a DNA binding protein involved in DNA damage responses, morphogenesis, and virulence. Eukaryot Cell (2009) 0.99
ADAM19/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. Curr Pharm Des (2009) 0.98
The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling. J Biol Chem (2003) 0.98
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities. Biochem J (2004) 0.98
Comamonas (Pseudomonas) testosteroni endocarditis. Cardiovasc Pathol (2005) 0.98
Active roles of tumor stroma in breast cancer metastasis. Int J Breast Cancer (2012) 0.98
Mechanism of glycan receptor recognition and specificity switch for avian, swine, and human adapted influenza virus hemagglutinins: a molecular dynamics perspective. J Am Chem Soc (2009) 0.97
Methodology and applications of disease biomarker identification in human serum. Biomark Insights (2007) 0.97
Phase II trial of dolastatin-10 in patients with advanced breast cancer. Invest New Drugs (2005) 0.97
Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate (2003) 0.96
Enhancing QM/MM molecular dynamics sampling in explicit environments via an orthogonal-space-random-walk-based strategy. J Phys Chem B (2011) 0.95
Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report. Case Rep Endocrinol (2012) 0.95
Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity. BMC Cancer (2010) 0.94
The Candida albicans phosphatase Inp51p interacts with the EH domain protein Irs4p, regulates phosphatidylinositol-4,5-bisphosphate levels and influences hyphal formation, the cell integrity pathway and virulence. Microbiology (2008) 0.93
The role of mammography in male patients with breast symptoms. Mayo Clin Proc (2007) 0.93
Anion exchange fractionation of serum proteins versus albumin elimination. Anal Biochem (2007) 0.93
A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect Prev (2005) 0.92
Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. Int J Radiat Oncol Biol Phys (2010) 0.92
ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein. J Biol Chem (2011) 0.92
Macrophage migration inhibitory factor is released as a complex with alpha1-inhibitor-3 in the intraluminal fluid during bladder inflammation in the rat. J Urol (2005) 0.91
Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites. J Biol Chem (2002) 0.91
Quality of life of men with biochemical recurrence of prostate cancer. J Psychosoc Oncol (2008) 0.91
Current therapeutic strategies for invasive and metastatic bladder cancer. Onco Targets Ther (2011) 0.90
MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells. BMC Cancer (2008) 0.90
A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors. Stem Cells (2014) 0.90
Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer. PLoS One (2013) 0.90
Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents. Med Res Rev (2011) 0.89
Uncoupling of oxidative phosphorylation enables Candida albicans to resist killing by phagocytes and persist in tissue. Cell Microbiol (2006) 0.89
Isoelectric point-based prefractionation of proteins from crude biological samples prior to two-dimensional gel electrophoresis. J Proteome Res (2005) 0.89
Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action. Int J Cancer (2005) 0.89
Urothelial carcinoma recurrence in ileal orthotopic neobladder: urethrectomy and creation of ileal conduit. Urology (2007) 0.89
The post-Katrina conversion of clinics in New Orleans to medical homes shows change is possible, but hard to sustain. Health Aff (Millwood) (2012) 0.88
Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod (2002) 0.88
Spindle cell lesions of the bladder and urinary tract. Histopathology (2009) 0.87
Incentivizing primary care providers to innovate: building medical homes in the post-Katrina New Orleans safety net. Health Serv Res (2013) 0.86
Transforming primary care in the New Orleans safety-net: the patient experience. Med Care (2013) 0.86
Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype. Clin Exp Metastasis (2010) 0.85
Autolytic processing at Glu586-Ser587 within the cysteine-rich domain of human adamalysin 19/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. J Biol Chem (2002) 0.85
P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens. Am J Clin Pathol (2004) 0.84
RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer. Gynecol Oncol (2011) 0.84
The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapy. PLoS One (2013) 0.84
Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice. Neurourol Urodyn (2010) 0.84
Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis. Med Hypotheses (2006) 0.84
Novel stromal biomarkers in human breast cancer tissues provide evidence for the more malignant phenotype of estrogen receptor-negative tumors. J Biomed Biotechnol (2011) 0.84
Quality of life of patients undergoing surgical treatment for newly-diagnosed, clinically localized renal cell carcinoma. J Psychosoc Oncol (2011) 0.84
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors. Biochem J (2005) 0.83
Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma. Brain Pathol (2008) 0.83
Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer. Prostate (2012) 0.82
Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Prostate (2011) 0.82
Sorafenib-induced pancreatitis. Mayo Clin Proc (2007) 0.81
Protein profiling of isolated leukocytes, myofibroblasts, epithelial, Basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues. J Cancer (2010) 0.81
c-MET expression in primary and liver metastases in uveal melanoma. Melanoma Res (2014) 0.81
Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion. Biochem J (2007) 0.81
Renal epithelioid angiomyolipoma with a negative premelanosome marker immunoprofile: a case report and review of the literature. J Med Case Rep (2013) 0.81
Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate. Prostate (2014) 0.80
Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of life. J Gen Intern Med (2008) 0.80
The launch of the american journal of translational research. Am J Transl Res (2009) 0.80
Prefractionation enhances loading capacity and identification of basic proteins from human breast cancer tissues. Anal Biochem (2010) 0.80
Treatment of men with rising prostate-specific antigen levels following radical prostatectomy. Expert Rev Anticancer Ther (2011) 0.80
Papular elastolytic giant cell granuloma responding to hydroxychloroquine and quinacrine. Int J Dermatol (2004) 0.80
Expression of adamalysin 19/ADAM19 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy. Mol Hum Reprod (2005) 0.80